Hämorheologische Erkrankungen: Thrombozytose — Polyzythämie — lokale Thrombose — Mikroembolie

  • K. Alexander
Chapter
Part of the Klinische Radiologie book series (KLINRAD)

Zusammenfassung

Unter dem Oberbegriff „hämorheologische Erkrankungen“ werden an dieser Stelle die myeloproliferativen Syndrome, vor allem exemplarisch die essentielle Thrombozythämie, daneben die Polycythämia vera als Hauptursache lokaler Thrombosen abgehandelt, während plasmatische Gerinnungsstörungen als Ursache arterieller Verschlußprozesse ausgeklammert bleiben, da sie hämorheologischen Erkrankungen im engeren Sinne nicht zuzurechnen sind. Auf der anderen Seite gewinnt im Zeitalter der invasivdiagnostischen und der interventionellen Radiologie die Mobilisation orstständigen wandadhärenten Gefäßmaterials mit embolischer Verschleppung zunehmend an Bedeutung; als Beispiel sog. Mikroembolien wird deshalb die Cholesterinkristallembolie gesondert abgehandelt

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Anger B, Haug U, Seidler R, Heimpel H (1989) Polycythemia vera. A clinical study of 141 patients. Blut 59:493–500PubMedCrossRefGoogle Scholar
  2. 2.
    Barbui T, Buelli M, Cortelazzo S, Viero P (1987) Aspirin and risk of bleeding in patients with thrombocythemia. Am J Med 83:265–268PubMedCrossRefGoogle Scholar
  3. 3.
    Belucci S, Janvier M, Tobelem G, Flandrin G, Charpak Y, Berger R, Boiron M (1986) Essential thrombocythemias. Cancer 58:2440–2447CrossRefGoogle Scholar
  4. 4.
    Colt HG, Begg RJ, Saporito JJ, Cooper WM, Shapiro AP (1988) Cholesterolemboli after cardiac catheterization. Medicine 67:389–400PubMedCrossRefGoogle Scholar
  5. 5.
    Cortelazzo S, Viero P, Finazzi G, D’Emilio A, Rodeghiero F, Barbui T (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 8:556–562PubMedGoogle Scholar
  6. 6.
    Dahlberg PJ, Frecentese DF, Cogbill TH (1989) Cholesterol embolism: Experience with 22 histologically proven cases. Surgery 105:737–746PubMedGoogle Scholar
  7. 7.
    Falanga V, Fine MJ, Kapoor WN (1986) The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 122:1194–1198PubMedCrossRefGoogle Scholar
  8. 8.
    Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F (1990) Clinical course of essential thrombocythemia in 147 cases. Cancer 66:549–556PubMedCrossRefGoogle Scholar
  9. 9.
    Fine MJ, Kapoor W, Falanga V (1987) Cholesterol crystal embolization: a review of 221 cases in the english literature. Angiol 38:769–784CrossRefGoogle Scholar
  10. 10.
    Fisher DF, Clagetti GP, Brigham RA, Oreccia PM, Youkey JR, Aronoff RJ, Fry RE, Fry WJ (1984) Dilemmas in dealing with the blue toe syndrome: aortic versus peripheral source. Am J Surg 148:836–839PubMedCrossRefGoogle Scholar
  11. 11.
    Gaines PA, Kennedy A, Moorhead P, Cumberland DC, Welsh CL, Rutley MS (1988) Cholesterol embolisation: a lethal complication of vascular catheterisation. Lancet 1:168–170PubMedCrossRefGoogle Scholar
  12. 12.
    Hart RG, Kanter MC (1990) Hematologic disorders and ischemic stroke. Stroke 21:1111–1121PubMedCrossRefGoogle Scholar
  13. 13.
    Hehlmann R, Jahn M, Baumann B, Kopcke W (1988) Essential thrombocythemia. Cancer 61:2487–2496PubMedCrossRefGoogle Scholar
  14. 14.
    Hyman B, Landas SK, Ashman RF, Schelper RL, Robinson RA (1987) Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 82:1233–1237PubMedCrossRefGoogle Scholar
  15. 15.
    Karmody AM, Powers SR, Monaco VJ, Leather RP (1976) „Blue toe“ syndrome. Arch Surg 111:1263–1268PubMedCrossRefGoogle Scholar
  16. 16.
    Kennedy A, Cumberland D, Gaines P (1989) The pathology of cholesterol embolism arising as a complication of intra-aortic catheterization. Histopathol 15:515–521CrossRefGoogle Scholar
  17. 17.
    Lahuerta-Palacios JJ, Bornstein R, Fernández-Debora J et al. (1988) Controlled and uncontrolled thrombocytosis. Cancer 61:1207–1212PubMedCrossRefGoogle Scholar
  18. 18.
    Mashiah A, Pasik S, Hurwitz N (1988) Massive atheromatous emboli to both kidneys: A fatal complication following aortic surgery. J Cardiovasc Surg 29:60–62Google Scholar
  19. 19.
    Masuda J, Yutani C, Ogata J, Kuriyama Y, Yamaguchi T (1994) Atheromatous embolism in the brain: A clinicopathologic analysis of 15 autopsy cases. Neurol 44:1231–1237Google Scholar
  20. 20.
    Mc Intyre KJ, Hoagland HC, Silverstein MN, Petitt RM (1991) Essential thrombocythemia in young adults. Mayo Clin Proc 66:149–154Google Scholar
  21. 21.
    Millard FE, Hunter CS, Anderson M, Edelman MJ, Kosty MP, Luiken GA, Marino GG (1990) Clinical manifestations of essential thrombocythemia in young adults. Am J Hematol 33:27–31PubMedCrossRefGoogle Scholar
  22. 22.
    Mitus AJ, Barbui T, Shulman LN, Rosenthal DS, Viero P, Cortelazzo S, Schafer AI (1990) Hemostatic complications in young patients with essential thrombocythemia. J Med 88:371–375CrossRefGoogle Scholar
  23. 23.
    Park S, Schroeter AL, Park YS, Fortson J (1993) Purple toes and livido reticularis in a patient with cardiovascular disease taking Coumadin. Arch Dermatol 129:775–780Google Scholar
  24. 24.
    Rastetter J (1993) Die chronischen myeloproliferativen Erkrankungen (CMPE). In: Begemann H, Rastetter J (Hrsg) Klinische Hämatologie. Thieme, Stuttgart New York, 4. Aufl. S 543–545; 548–564Google Scholar
  25. 25.
    Scheffer MG, Michiels JJ, Simoons ML, Roelandt JRTC (1991) Thrombocythemia and coronary artery disease. Am Heart J 122:573–576PubMedCrossRefGoogle Scholar
  26. 26.
    Schwartz MW, McDonald GB (1987) Cholesterol embolization syndrome. JAMA 258:1934–1935PubMedCrossRefGoogle Scholar
  27. 27.
    Watson KV, Key N (1993) Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors. Brit J Haematology 83:198–203CrossRefGoogle Scholar
  28. 28.
    Wehmeier A, Daum I, Jamin H, Schneider W (1991) Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. Ann Hematol 63:101–106PubMedCrossRefGoogle Scholar
  29. 29.
    Weitz Z, Gafter U, Chagnac A, Levi J (1987) Cholesterol emboli in atherosclerotic patients: reports of four cases occuring spontaneously or complicating angioplasty and aortorenal bypass. J Am Geriatr Soc 35:357–359PubMedGoogle Scholar
  30. 30.
    Wolter M, Marsch WCH (1990) Rankenförmige Livedo — akutes Leitsymptom einer kutanen Cholesterinembolie. Dtsch Med Wochenschr 115:452–455PubMedCrossRefGoogle Scholar
  31. 31.
    Zaytsev P, Miller K, Pelletiere EV (1986) Cutaneous cholesterol emboli with infarction clinically mimicking heparin necrosis a case report. Angiology 37:471–476PubMedCrossRefGoogle Scholar
  32. 32.
    Zeitler E (1994) Angiographische Diagnostik und digitale Subtraktionsangiographie bei peripheren Gefäßprozessen. Internist 35:457–464PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • K. Alexander

There are no affiliations available

Personalised recommendations